Dr. Wong on treatment sequence in metastatic urothelial carcinoma

Risa Wong, MD, discusses the sequencing of treatments in the metastatic urothelial carcinoma armamentarium, including chemotherapy, immune checkpoint inhibitors, and antibody-drug conjugates. Wong is a hematology/oncology fellow at the University of Washington and Fred Hutchinson Cancer Research Center in Seattle.